Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study

Authors

Ziyue Gu (ORCID: https://orcid.org/0000-0002-8926-1754)
Shengjin Dou (ORCID: https://orcid.org/0000-0002-6530-641X)
Guopei Zhu (ORCID: https://orcid.org/0000-0003-4770-9458)
Lin Zhang (ORCID: https://orcid.org/0000-0003-4241-4351)
Rongrong Li (ORCID: https://orcid.org/0009-0001-7550-5869)
Jiang Li (ORCID: https://orcid.org/0000-0002-5539-8760)
Ge Wang (ORCID: https://orcid.org/0000-0001-8097-6318)
Debin Sun
Wen Hui Jiang (ORCID: https://orcid.org/0000-0002-4824-3883)
Yining He
Minjun Dong (ORCID: https://orcid.org/0000-0003-0445-8185)

Institutions

National Clinical Research Center for Digestive Diseases (CN)
Shanghai Stomatological Hospital (CN)
Shanghai Ninth People's Hospital (CN)
National Clinical Research (US)
Shanghai Clinical Research Center (CN)
Genecast (China) (CN)

Publication Details

Journal: Frontiers in Immunology
Published: 2025-10-13
DOI: https://doi.org/10.3389/fimmu.2025.1667733
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study

Ziyue Gu, Shengjin Dou, Guopei Zhu, Lin Zhang et al.

Oct 13, 2025

Frontiers in Immunology

Cancer Immunotherapy and Biomarkers

article

Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study

Ziyue Gu, Shengjin Dou, Guopei Zhu, Lin Zhang, Rongrong Li, Jiang Li, Ge Wang, Debin Sun, Wen Hui Jiang, Yining He, Minjun Dong

October 13, 2025article en

Abstract

No abstract available for this paper.

Frontiers in ImmunologyVol. 16

National Clinical Research Center for Digestive Diseases (CN), Shanghai Stomatological Hospital (CN), Shanghai Ninth People's Hospital (CN), National Clinical Research (US), Shanghai Clinical Research Center (CN), Genecast (China) (CN)

Openalex Percentile: Top 61%

Cancer Immunotherapy and Biomarkers

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study — Ziyue Gu, Shengjin Dou, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS